Search results for "Anticoagulation"
Apixaban safer, more effective than rivaroxaban for afib with heart disease, study finds
Apixaban was associated with a lower rate of ischemic stroke or systemic embolism and a lower rate of bleeding in a propensity-matched cohort study of commercially insured patients with atrial fibrillation (AF) and valvular heart disease.
https://immattersacp.org/weekly/archives/2022/10/18/2.htm
18 Oct 2022
DOACs associated with lower risk of fracture than warfarin in atrial fibrillation
Patients taking apixaban, dabigatran, or rivaroxaban had lower rates of hip and vertebral fractures than those taking warfarin, with no difference seen between the direct oral anticoagulants (DOACs).
https://immattersacp.org/weekly/archives/2020/05/19/2.htm
19 May 2020
Point-of-care screening did not affect diagnosis of afib in primary care, study finds
In a randomized trial at 16 primary care clinics in Massachusetts, rates of new afib diagnosis at one year were 1.72% with afib screening of older patients using a single-lead electrocardiogram versus 1.59% with usual care.
https://immattersacp.org/weekly/archives/2022/03/08/1.htm
8 Mar 2022
Anticoagulant choice for stroke won't be easy for some time
New agents improve upon warfarin, but they are expensive and lack antidotes for urgent reversal. There is no clear winner among the current options, and more are on the way.
https://immattersacp.org/archives/2013/10/shm.htm
1 Oct 2013
CDC updates guidance on COVID-19, studies show vitamins don't improve outcomes
The CDC offered new guidance on immunocompromised patients and pulse oximetry's accuracy, and recent trials showed that vitamin D, zinc, and ascorbic acid didn't help COVID-19 patients but prophylactic anticoagulation did.
https://immattersacp.org/weekly/archives/2021/02/23/1.htm
23 Feb 2021
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
New drugs could improve anticoagulation rates
Dabigatran and rivaroxaban spare patients the need for regular blood checks, but warfarin is less expensive and has an antidote to reverse bleeding, if needed. Does the convenience of the new generation of drugs and the potential to increase compliance with therapy outweigh their downsides?.
https://immattersacp.org/archives/2012/04/anticoagulation.htm
1 Apr 2012
MKSAP Quiz: Right-upper-quadrant abdominal discomfort
A 36-year-old woman is evaluated for a 3-day history of constant right-upper-quadrant abdominal discomfort and abdominal distention. She has no significant medical history. Following a physical exam and lab tests, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2021/10/19/3.htm
19 Oct 2021
AHA statement reviews efficacy, safety of CAM therapies in patients with heart failure
Potentially beneficial complementary and alternative medicine (CAM) therapies included omega-3 polyunsaturated fatty acids, coenzyme Q10, D-ribose, and L-carnitine, the American Heart Association (AHA) said.
https://immattersacp.org/weekly/archives/2022/12/13/1.htm
13 Dec 2022
Take TIAs as seriously as a stroke
Internal medicine physicians play a critical role in educating patients about the seriousness of transient ischemic attacks and preventing their recurrence.
https://immattersacp.org/archives/2023/05/take-tias-as-seriously-as-a-stroke.htm
1 May 2023